Literature DB >> 33237391

Subconjunctival injection of tumor necrosis factor-α pre-stimulated bone marrow-derived mesenchymal stem cells enhances anti-inflammation and anti-fibrosis in ocular alkali burns.

Nuan Zhang1, Xiaohui Luo1, Shiyao Zhang1, Ren Liu1, Lingyi Liang2, Wenru Su3, Dan Liang4.   

Abstract

PURPOSE: To investigate the therapeutic effect of subconjunctival injection of tumor necrosis factor-α (TNF-α) pre-stimulated bone marrow-derived mesenchymal stem cells (BMMSCs) on ocular alkali burns in a rat model.
METHODS: After applying a 6 mm filter paper soaking in 1 N NaOH on the cornea of rats, the suspension of TNF-α pre-stimulated BMMSCs, BMMSCs and PBS were given subconjunctivally and respectively. Corneal epithelial defect, corneal opacity, inflammation as well as PTGS2 and TSG-6 expression on day 7 and fibrosis on day 14 were compared.
RESULTS: TNF-α pre-stimulated BMMSCs group had a more predominate effect on promoting corneal epithelial repairing, decreasing corneal opacity, reducing inflammatory cells and CD68 + macrophages on day 7 and suppressing fibrosis on day 14 compared to BMMSCs group. Besides, it had significant increased expressions of PTGS2 and TSG-6 in vitro. Pre-treated with Indomethacin revealed a reverse effect on above-mentioned changes.
CONCLUSION: Subconjunctival injection of TNF-α pre-stimulated BMMSCs enhanced anti-inflammatory and anti-fibrotic effect in ocular alkali burns, which was possibly though up regulation of PTGS2 and TSG-6 expression.

Entities:  

Keywords:  Anti-fibrosis; Anti-inflammation; Bmmscs; Ocular alkali burns; TNF-α

Mesh:

Substances:

Year:  2020        PMID: 33237391     DOI: 10.1007/s00417-020-05017-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

Review 1.  Immunomodulatory properties of mesenchymal stromal cells.

Authors:  Alma J Nauta; Willem E Fibbe
Journal:  Blood       Date:  2007-07-30       Impact factor: 22.113

2.  Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Authors:  Rosa Yañez; María Luisa Lamana; Javier García-Castro; Isabel Colmenero; Manuel Ramírez; Juan A Bueren
Journal:  Stem Cells       Date:  2006-07-27       Impact factor: 6.277

3.  Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats.

Authors:  Lingjun Zhang; Hui Zheng; Hui Shao; Hong Nian; Yan Zhang; Lingling Bai; Chang Su; Xun Liu; Lijie Dong; Xiaorong Li; Xiaomin Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

4.  Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells.

Authors:  Eliska Javorkova; Peter Trosan; Alena Zajicova; Magdalena Krulova; Michaela Hajkova; Vladimir Holan
Journal:  Stem Cells Dev       Date:  2014-07-01       Impact factor: 3.272

5.  Clinical characteristics and visual outcome of severe ocular chemical injuries in Shanghai.

Authors:  Jiaxu Hong; Ting Qiu; Angi Wei; Xinghuai Sun; Jianjiang Xu
Journal:  Ophthalmology       Date:  2010-06-29       Impact factor: 12.079

6.  Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study.

Authors:  Jun Liang; Huayong Zhang; Bingzhu Hua; Hong Wang; Liwei Lu; Songtao Shi; Yayi Hou; Xiaofeng Zeng; Gary S Gilkeson; Lingyun Sun
Journal:  Ann Rheum Dis       Date:  2010-08       Impact factor: 19.103

7.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

8.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

Review 9.  Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.

Authors:  Samuel Golpanian; Ariel Wolf; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

10.  Epidemiologic Trends of Chemical Ocular Burns in the United States.

Authors:  R Sterling Haring; Isaac D Sheffield; Roomasa Channa; Joseph K Canner; Eric B Schneider
Journal:  JAMA Ophthalmol       Date:  2016-10-01       Impact factor: 7.389

View more
  5 in total

1.  Tumor necrosis factor-alpha stimulated gene-6: A biomarker reflecting disease activity in rheumatoid arthritis.

Authors:  Tingting Hu; Yuhan Liu; Xu Li; Xiaohang Li; Yanzhao Liu; Qunxia Wang; Jiayi Huang; Jianlin Yu; Yang Wu; Simei Chen; Tingting Zeng; Liming Tan
Journal:  J Clin Lab Anal       Date:  2022-03-30       Impact factor: 3.124

Review 2.  Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art.

Authors:  Sara Galindo; Ana de la Mata; Marina López-Paniagua; Jose M Herreras; Inmaculada Pérez; Margarita Calonge; Teresa Nieto-Miguel
Journal:  Stem Cell Res Ther       Date:  2021-01-13       Impact factor: 6.832

Review 3.  Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives.

Authors:  Fabiana Mallone; Roberta Costi; Marco Marenco; Rocco Plateroti; Antonio Minni; Giuseppe Attanasio; Marco Artico; Alessandro Lambiase
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

Review 4.  Ocular Drug Delivery: Advancements and Innovations.

Authors:  Bo Tian; Evan Bilsbury; Sean Doherty; Sean Teebagy; Emma Wood; Wenqi Su; Guangping Gao; Haijiang Lin
Journal:  Pharmaceutics       Date:  2022-09-13       Impact factor: 6.525

5.  Recombinant TSG-6 protein inhibits the growth of capsule fibroblasts in frozen shoulder via suppressing the TGF-β/Smad2 signal pathway.

Authors:  Zhongfan Liu; Yongrong Pei; Hao Zeng; Yibo Yang; Meng Que; Yuhui Xiao; Jing Wang; Xiaojun Weng
Journal:  J Orthop Surg Res       Date:  2021-09-15       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.